Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02
Published January 28, 2026 · Recall initiated: January 16, 2026
Summary
FDA records drug Class II recall D-0294-2026, published January 28, 2026 and initiated January 16, 2026. Recalling firm: Specialty Process Labs LLC; Status: Ongoing; Reported quantity: 58 gms; Lot: Lot #H22254-1XV; Exp. 01/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Specialty Process Labs LLC
- Distributor
- U.S. Nationwide
- Lot
- Lot #H22254-1XV; Exp. 01/31/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFurosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., EastJanuary 28, 2026
- FDAIcosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd.,January 28, 2026
- FDADiclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 EJanuary 28, 2026
- FDAAustralian Greenlip Abalone, Frozen, 9 pieces, Net Wt. 23.5 OZ UPC: 9335533013342January 28, 2026
- FDAS.P Labs, Thyroid, USP, Rx only, For Manufacturing, Processing or Repackaging Use only, Specialty ProcessApril 24, 2024
- FDAS.P.Labs, Thyroid, Full Strength, Rx only, For Manufacturing, Processing or Repackaging Use Only, SpecialtyApril 24, 2024
Questions about this recall
Was Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02 recalled?
Yes. FDA published recall D-0294-2026 on January 28, 2026. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter